Blue Jet Healthcare's stock is set to go public on the market today. Blue Jet Healthcare's GMP increased by 6.36% prior to its IPO. The initial public offering was subscribed 7.95 times. The category for Qualified Institutional Buyers (QIBs) was subscribed 13.72 times, the portion for non-institutional investors was subscribed 13.59 times, and the Retail Individual Investors (RIIs) quota was subscribed 2.24 times.
"Blue Jet Healthcare will make its secondary market debut." The company's GMP is currently at Rs 20, indicating a good listing. Based on the IPO's upper price band of Rs 346, the expected listing price of Blue Jet Healthcare shares is Rs 366, a 5 to 6 percent premium. The issue received 7.95 subscriptions.
The company produces contrast media intermediates and high-intensity sweeteners, and it benefits from high entry hurdles and long-term relationships with global customers. Given the current GMP and market mood, Blue Jet Healthcare is likely to see a flat to positive listing," said Shivani Nyati, Head of Wealth at Swastika Investmart.
Blue Jet Healthcare's first public offering (IPO) began on Wednesday, October 25, 2023 and ended on Friday, October 27, 2023. The price range for its public offering is Rs 329-346 per equity share with a face value of Rs 2 each. The company's promoters and shareholders hope to raise Rs 840.27 crore from the IPO at the upper end of the pricing band.
Blue Jet Healthcare Its initial public offering price range is Rs 329-346 per equity share with a face value of Rs 2 each. The promoters and shareholders of the company expect to raise Rs 840.27 crore from the IPO at the upper end of the pricing band.
